Wheelchair Market Growth Growth & Trends Trends
The global wheelchair market size is expected to reach USD 4.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.0% from 2021 to 2028. The Americans with Disabilities Act (ADA) defines a wheelchair as a manually operated or automated device, designed primarily for use by an individual with a mobility disability. It is mainly used for the purpose of indoor or both indoor and outdoor locomotion. Increase in life span and numbers of elderly persons at a global level is one of the key reasons expected to contribute towards the growth of the market.
The growing integration of automation in healthcare devices, especially mobility devices, such as wheelchairs is a key impacting parameter, projected to support market growth. Wheelchairs today are incorporated with non-linear processing circuits, guide sensors, pulse steering drive, and several controls for making the ride easy and smooth for patients.
Rise in number of disorders requiring a mobility device is also one of the key factors expected to contribute to market growth. One of the common disabilities that require a mobility device is the spinal cord injuries. According to the National Spinal Cord Injury Statistical Center’s Facts and Figures at a Glance 2020, there are around 294,000 people currently living with spinal cord injuries (SCI), in the U.S. with 17,810 new cases each year. Thus, the US is expected to be a key potential market for the manufacturers of the mobility device in the years to come.
The recent COVID-19 pandemic affected the manufacturing and supply chain aspect of the manufacturers to a great extent. Wheelchair services were halted across several countries owing to strict lockdowns being implemented. This had left many wheelchair users in a fix. The manufacturers also faced difficulty since their operations were halted. Although the number of hospital visits by regular patients had reduced during the lockdown, the number of patients affected with COVID-19 witnessed a spike. Thus, demand for the mobility device increased during this period, especially from the hospital segment. With the ease of lockdowns, the manufacturing operation of the mobility device is expected to come back to normal.
Wheelchair Market Report Highlights
- The manual product segment led the segment in terms of revenue share in 2020 owing to its increasing use in hospitals. It is also cost-effective and requires little maintenance
- Rising volume of medical emergencies is a prime factor driving the hospital segment
- The adults segment was the largest in 2020 in terms of revenue share owing to rise in number of disabilities requiring a mobility device such as the spinal cord injuries and an expanding ageing population
- North America dominated the market with a revenue share of 35.0% due to increased adoption of advanced technology in wheelchairs and rise in the disabled population
Please note: The report will be updated with the latest data and delivered to you within 2-3 business days.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Category
- 1.1.3. Application
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1:
- 1.9.2. Objective 2:
- 1.9.3. Objective 3:
- 1.9.4. Objective 4:
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Wheelchairs Market Variables, Trends & Scope
- 3.1. Penetration & Growth Prospect Mapping
- 3.2. Industry Value Chain Analysis
- 3.2.1. Reimbursement framework
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.3.3. Industry challenges
- 3.4. Wheelchairs Market Analysis Tools
- 3.4.1. Industry Analysis – Porter’s
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
- 3.4.3. Major Deals & Strategic Alliances Analysis
- 3.4.4. Market Entry Strategies
- Chapter 4. Wheelchairs Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Definitions and Scope
- 4.3. Wheelchairs Market Share, 2020 & 2028
- 4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
- 4.4.1. Manual
- 4.4.2. Electric
- Chapter 5. Wheelchairs Market: Category Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Definitions and Scope
- 5.3. Wheelchairs Market Share, 2020 & 2028
- 5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
- 5.4.1. Adult
- 5.4.2. Pediatric
- Chapter 6. Wheelchairs Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Dashboard
- 6.2. Regional Market Share Analysis, 2020 & 2028
- 6.3. Regional Market Share, 2020
- 6.4. North America
- 6.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.4.2. U.S.
- 6.4.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.4.3. Canada
- 6.4.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.5. Europe
- 6.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.5.2. U.K.
- 6.5.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.5.3. Germany
- 6.5.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.5.4. France
- 6.5.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.5.5. Italy
- 6.5.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.5.6. Spain
- 6.5.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.6. Asia Pacific
- 6.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.6.2. Japan
- 6.6.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.6.3. China
- 6.6.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.6.4. India
- 6.6.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.6.5. Australia
- 6.6.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.6.6. South Korea
- 6.6.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.7. Latin America
- 6.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.7.2. Brazil
- 6.7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.7.3. Mexico
- 6.7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.7.4. Argentina
- 6.7.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.7.5. Colombia
- 6.7.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8. MEA
- 6.8.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8.2. South Africa
- 6.8.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8.3. Saudi Arabia
- 6.8.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 6.8.4. UAE
- 6.8.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.1.1. Carex Health Brands, Inc.
- 7.1.1.1. Company overview
- 7.1.1.2. Financial performance
- 7.1.1.3. Product benchmarking
- 7.1.1.4. Strategic initiatives
- 7.1.2. Drive Medical Design & Manufacturing
- 7.1.2.1. Company overview
- 7.1.2.2. Financial performance
- 7.1.2.3. Product benchmarking
- 7.1.2.4. Strategic initiatives
- 7.1.3. Graham-Field Health Products Inc.
- 7.1.3.1. Company overview
- 7.1.3.2. Financial performance
- 7.1.3.3. Product benchmarking
- 7.1.3.4. Strategic initiatives
- 7.1.4. Invacare
- 7.1.4.1. Company overview
- 7.1.4.2. Financial performance
- 7.1.4.3. Product benchmarking
- 7.1.4.4. Strategic initiatives
- 7.1.5. Medline
- 7.1.5.1. Company overview
- 7.1.5.2. Financial performance
- 7.1.5.3. Product benchmarking
- 7.1.5.4. Strategic initiatives
- 7.1.6. Sunrise Medical LLC
- 7.1.6.1. Company overview
- 7.1.6.2. Financial performance
- 7.1.6.3. Product benchmarking
- 7.1.6.4. Strategic initiatives
- 7.1.7. Karman Healthcare
- 7.1.7.1. Company overview
- 7.1.7.2. Financial performance
- 7.1.7.3. Product benchmarking
- 7.1.7.4. Strategic initiatives
- 7.1.8. Quantum Rehab
- 7.1.8.1. Company overview
- 7.1.8.2. Financial performance
- 7.1.8.3. Product benchmarking
- 7.1.8.4. Strategic initiatives
- 7.1.9. Numotion
- 7.1.9.1. Company overview
- 7.1.9.2. Financial performance
- 7.1.9.3. Product benchmarking
- 7.1.9.4. Strategic initiatives
- 7.1.10. Pride Mobility Products Corp.
- 7.1.10.1. Company overview
- 7.1.10.2. Financial performance
- 7.1.10.3. Product benchmarking
- 7.1.10.4. Strategic initiatives